CIK 0000832489 · Non-accelerated filer<br>Smaller reporting company
GeoVax Labs, Inc.
Sign in to watch- Ticker
- GOVX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870455038
- Phone
- 678-384-7220
- Business address
- 1955 LAKE PARK DRIVE, SUITE 300, SMYRNA, GA
- Former names
- DAUPHIN TECHNOLOGY INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | SPENCER JOHN N JR Director | Grant or award · Stock Option | +6,000 | 6,000 | ||
| 2026-06-17 | Morgan Jayne Director | Grant or award · Stock Option | +6,000 | 6,000 | ||
| 2026-06-17 | MCNALLY ROBERT T Director | Grant or award · Stock Option | +6,000 | 6,000 | ||
| 2026-06-17 | Lemerond Nicole Director | Grant or award · Stock Option | +6,000 | 6,000 | ||
| 2026-06-17 | Kollintzas Dean G Director | Grant or award · Stock Option | +6,000 | 6,000 | ||
| 2026-06-17 | CHASE RANDAL D Director | Grant or award · Stock Option | +6,000 | 6,000 | ||
| 2026-06-17 | Sharkey John W. VP, Business Development | Grant or award · Stock Option | +17,600 | 17,600 | ||
| 2026-06-17 | Reynolds Mark CFO | Grant or award · Stock Option | +17,600 | 17,600 | ||
| 2026-06-17 | NEWMAN MARK J Chief Scientific Officer | Grant or award · Stock Option | +17,600 | 17,600 | ||
| 2026-06-17 | McKee Kelly T. Jr. Chief Medical Officer | Grant or award · Stock Option | +17,600 | 17,600 | ||
| 2026-06-17 | DODD DAVID A President, CEO | Grant or award · Stock Option | +29,300 | 29,300 | ||
| 2025-10-17 | SPENCER JOHN N JR Director | Purchase | +10,000 | $0.55 | $5K | 21,402 |
| 2025-08-07 | McKee Kelly T. Jr. Chief Medical Officer | Purchase | +1,107 | $0.67 | $742 | 3,494 |
| 2025-06-05 | Lemerond Nicole Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2025-06-05 | CHASE RANDAL D Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2025-06-05 | Kollintzas Dean G Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2025-06-05 | MCNALLY ROBERT T Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2025-06-05 | Morgan Jayne Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2025-06-05 | SPENCER JOHN N JR Director | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2025-06-05 | NEWMAN MARK J Chief Scientific Officer | Grant or award · Stock Option | +70,000 | 70,000 |
Page 1 of 6 · 107 trades